| (Values in U.S. Thousands) | Mar, 2025 | Mar, 2024 | Mar, 2023 | Mar, 2022 | Mar, 2021 |
| Sales | 10,101,670 | 9,930,690 | 10,057,450 | 10,229,390 | 10,071,660 |
| Sales Growth | +1.72% | -1.26% | -1.68% | +1.57% | -0.48% |
| Net Income | 463,800 | 601,130 | 696,090 | 673,950 | 558,510 |
| Net Income Growth | -22.85% | -13.64% | +3.29% | +20.67% | +222.28% |
Ajinomoto Company Inc ADR (AJINY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
AJINOMOTO GROUP has continued to create new value by deepening its knowledge of amino acids and expanding into fields such as health and pharmaceuticals while developing a new dietary culture. Today, they offer a variety of products worldwide, including seasonings, processed foods, beverages, pharmaceuticals, amino acids and specialty chemicals.
Fiscal Year End Date: 03/31